Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EDAP EDAP TMS	$1.67 -2.6%	$1.87	$1.26 ▼ $5.46	$62.44M	0.02	98,191 shs	60,311 shs
MLSS Milestone Scientific	$0.73 -4.3%	$0.92	$0.57 ▼ $1.39	$57.05M	0.9	128,376 shs	364,213 shs
TELA TELA Bio	$1.97 +6.5%	$1.38	$0.86 ▼ $5.18	$77.92M	0.78	217,510 shs	66,433 shs
VVOS Vivos Therapeutics	$3.28 -2.7%	$2.54	$1.97 ▼ $6.28	$19.32M	7.03	471,479 shs	133,539 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EDAP EDAP TMS	0.00%	-1.65%	-6.70%	-22.33%	-67.70%
MLSS Milestone Scientific	0.00%	-17.28%	-23.87%	-26.57%	+11.50%
TELA TELA Bio	0.00%	+19.39%	+44.85%	+59.51%	-62.04%
VVOS Vivos Therapeutics	0.00%	+17.14%	+31.73%	+5.47%	+50.46%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EDAP EDAP TMS	2.9503 of 5 stars	3.2	5.0	2.2	1.7	0.6
MLSS Milestone Scientific	2.6344 of 5 stars	3.5	5.0	0.6	2.5	0.0
TELA TELA Bio	3.2841 of 5 stars	3.4	5.0	2.7	1.7	0.6
VVOS Vivos Therapeutics	1.8463 of 5 stars	3.3	2.0	2.8	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EDAP EDAP TMS	2.33	Hold	$8.50	408.98% Upside
MLSS Milestone Scientific	3.00	Buy	$1.25	71.94% Upside
TELA TELA Bio	2.75	Moderate Buy	$7.25	268.02% Upside
VVOS Vivos Therapeutics	2.50	Moderate Buy	$4.82	46.85% Upside

Current Analyst Ratings Breakdown

Latest VVOS, TELA, EDAP, and MLSS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/20/2025	VVOS Vivos Therapeutics	Industrial Alliance Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$2.25
5/20/2025	VVOS Vivos Therapeutics	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
5/15/2025	EDAP EDAP TMS	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral
4/15/2025	VVOS Vivos Therapeutics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$6.60 ➝ $6.20
4/4/2025	EDAP EDAP TMS	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$8.00 ➝ $2.00
4/1/2025	VVOS Vivos Therapeutics	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EDAP EDAP TMS	$69.18M	0.90	N/A	N/A	$1.18 per share	1.42
MLSS Milestone Scientific	$8.61M	6.62	N/A	N/A	$0.11 per share	6.61
TELA TELA Bio	$69.30M	1.12	N/A	N/A	$0.72 per share	2.74
VVOS Vivos Therapeutics	$15.03M	1.29	N/A	N/A	$1.35 per share	2.43

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EDAP EDAP TMS	-$20.58M	-$0.62	N/A	N/A	N/A	-34.45%	-51.42%	-26.43%	8/27/2025 (Estimated)
MLSS Milestone Scientific	-$6.93M	-$0.07	N/A	∞	N/A	-52.01%	-60.26%	-40.23%	N/A
TELA TELA Bio	-$37.84M	-$1.41	N/A	N/A	N/A	-61.00%	-402.45%	-62.73%	8/11/2025 (Estimated)
VVOS Vivos Therapeutics	-$11.14M	-$1.73	N/A	N/A	N/A	-76.82%	-170.43%	-77.82%	8/13/2025 (Estimated)

Latest VVOS, TELA, EDAP, and MLSS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/15/2025	Q1 2025	EDAP EDAP TMS	-$0.16	-$0.20	-$0.04	-$0.20	$16.56 million	$16.37 million
5/15/2025	Q1 2025	VVOS Vivos Therapeutics	-$0.44	-$0.45	-$0.01	-$0.45	$3.63 million	$3.70 million
5/8/2025	Q1 2025	TELA TELA Bio	-$0.21	-$0.25	-$0.04	-$0.25	$17.35 million	$18.52 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EDAP EDAP TMS	N/A	N/A	N/A	N/A	N/A
MLSS Milestone Scientific	N/A	N/A	N/A	N/A	N/A
TELA TELA Bio	N/A	N/A	N/A	N/A	N/A
VVOS Vivos Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EDAP EDAP TMS	0.10	1.74	1.21
MLSS Milestone Scientific	N/A	2.85	1.86
TELA TELA Bio	2.28	4.22	3.40
VVOS Vivos Therapeutics	N/A	0.77	0.77

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EDAP EDAP TMS	62.74%
MLSS Milestone Scientific	5.79%
TELA TELA Bio	94.35%
VVOS Vivos Therapeutics	26.35%

Insider Ownership

Company	Insider Ownership
EDAP EDAP TMS	0.23%
MLSS Milestone Scientific	24.75%
TELA TELA Bio	4.70%
VVOS Vivos Therapeutics	3.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EDAP EDAP TMS	230	37.39 million	37.31 million	Optionable
MLSS Milestone Scientific	30	78.48 million	58.61 million	Optionable
TELA TELA Bio	120	39.56 million	37.70 million	Optionable
VVOS Vivos Therapeutics	160	5.89 million	5.71 million	Optionable

VVOS, TELA, EDAP, and MLSS Headlines

Recent News About These Companies

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

June 26 at 12:24 PM | finance.yahoo.com

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

June 26 at 8:30 AM | globenewswire.com

Vivos Therapeutics, Inc: Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada

June 11, 2025 | finanznachrichten.de

Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada

June 11, 2025 | finance.yahoo.com

Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada, Expanding OSA Diagnostic and Treatment Capabilities

June 11, 2025 | quiverquant.comQ

Vivos Therapeutics Secures $1.1M Convertible Note

May 23, 2025 | tipranks.com

Earnings call transcript: Vivos Therapeutics reports Q1 2025 earnings, stock rises

May 17, 2025 | uk.investing.com

Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

May 17, 2025 | finanznachrichten.de

Vivos Therapeutics Inc (VVOS) Q1 2025 Earnings Call Highlights: Strategic Acquisitions and FDA ...

May 17, 2025 | finance.yahoo.com

Vivos Therapeutics’ Earnings Call: Strategic Shifts Amid Financial Challenges

May 16, 2025 | tipranks.com

Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript

May 15, 2025 | seekingalpha.com

Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates

May 15, 2025 | zacks.com

Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

May 15, 2025 | finance.yahoo.com

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

May 15, 2025 | finance.yahoo.com

Vivos Therapeutics, Inc. to Release First Quarter 2025 Financial Results on May 15, 2025

May 14, 2025 | quiverquant.comQ

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

May 14, 2025 | globenewswire.com

Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

May 6, 2025 | zacks.com

Vivos to acquire sleep center

April 17, 2025 | hmenews.comH

Vivos Therapeutics announces agreement to acquire operating assets of SCN

April 17, 2025 | markets.businessinsider.com

Vivos Opens New Sleep Center

April 16, 2025 | baystreet.ca

New MarketBeat Followers Over Time

Media Sentiment Over Time

VVOS, TELA, EDAP, and MLSS Company Descriptions

EDAP TMS NASDAQ:EDAP

$1.67 -0.05 (-2.62%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$1.66 0.00 (-0.30%)

As of 06/27/2025 05:54 PM Eastern

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

Milestone Scientific NYSE:MLSS

$0.73 -0.03 (-4.34%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$0.72 -0.01 (-0.83%)

As of 06/27/2025 06:30 PM Eastern

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

TELA Bio NASDAQ:TELA

$1.97 +0.12 (+6.49%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$1.94 -0.03 (-1.78%)

As of 06/27/2025 05:29 PM Eastern

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Vivos Therapeutics NASDAQ:VVOS

$3.28 -0.09 (-2.67%)

Closing price 06/27/2025 04:00 PM Eastern

Extended Trading

$3.31 +0.03 (+0.95%)

As of 06/27/2025 07:59 PM Eastern

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time